Home / Japan / Nxera Pharma Co.,Ltd.
Nxera Pharma Co.,Ltd.
Short position disclosed on August 5, 2026.
2.69% of the capital sold short
2 disclosing funds
4 disclosures on record
Evolution of the disclosed total
0%1%2%3%
Aug 4Aug 5Aug 6Aug 7Aug 8Aug 9Aug 10
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Goldman Sachs International | 1.60% | new | August 5, 2026 | |
| Barclays Capital Securities Ltd | 1.09% | +0.14 pt | August 5, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| August 5, 2026 | Goldman Sachs International | 1.60% | still open |
| August 5, 2026 | Barclays Capital Securities Ltd | 1.09% | still open |
| August 3, 2026 | Citigroup Global Markets Limited | 1.00% | still open |
| August 3, 2026 | Barclays Capital Securities Ltd | 0.95% | still open |
Other companies sold short in Japan
- KLab Inc. 15.97% of the capital sold short
- ReYuu Japan Inc. 14.23% of the capital sold short
- Unitika LTD. 13.50% of the capital sold short
- 3-D Matrix,Ltd. 10.71% of the capital sold short
- Kasumigaseki Capital Co.,Ltd. 9.76% of the capital sold short
- Fixstars Corporation 9.68% of the capital sold short
- Asahi Diamond Industrial Co.,Ltd. 9.58% of the capital sold short
- Howa Machinery,Ltd. 9.32% of the capital sold short
- SHIFT Inc. 8.96% of the capital sold short
- Oncolys BioPharma Inc. 8.78% of the capital sold short
- Jibannet Holdings Co.,Ltd. 8.76% of the capital sold short
- Nippon Chemical Industrial Co.,Ltd. 8.16% of the capital sold short